BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4403948)

  • 1. Interaction of safrole and isosafrole with hepatic microsomal haemoproteins.
    Lake BG; Parke DV
    Biochem J; 1972 Apr; 127(2):23P. PubMed ID: 4403948
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of a new hepatic microsomal haemoprotein by safrole and isosafrole.
    Parke DV; Rahman H
    Biochem J; 1971 Jun; 123(2):9P-10P. PubMed ID: 5127349
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction of isosafrole in vivo with rat hepatic microsomal cytochrome P-450 following treatment with phenobarbitone or 20-methylcholanthrene.
    Fennell TR; Dickins M; Bridges JW
    Biochem Pharmacol; 1979 Apr; 28(8):1427-9. PubMed ID: 444308
    [No Abstract]   [Full Text] [Related]  

  • 4. Amino-terminal and carboxy-terminal sequence of hepatic microsomal cytochrome P-450d, a unique hemoprotein from rats treated with isosafrole.
    Botelho LH; Ryan DE; Yuan PM; Kutny R; Shively JE; Levin W
    Biochemistry; 1982 Mar; 21(6):1152-5. PubMed ID: 7074072
    [No Abstract]   [Full Text] [Related]  

  • 5. A novel haemoprotein induced by isosafrole pretreatment in the rat.
    Dickins M; Bridges JW; Elcombe CR; Netter KJ
    Biochem Biophys Res Commun; 1978 Jan; 80(1):89-96. PubMed ID: 623660
    [No Abstract]   [Full Text] [Related]  

  • 6. Interactions of safrole and isosafrole and their metabolites with cytochromes P-450.
    Ioannides C; Delaforge M; Parke DV
    Chem Biol Interact; 1985 May; 53(3):303-11. PubMed ID: 4006010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of promethazine and isosafrole on rat-hepatic microsomal mono-oxygenase activity: comparison with classic inducers phenobarbitone and beta-naphthoflavone.
    Taylor G; Houston JB; Elcombe CR
    Xenobiotica; 1985 Mar; 15(3):243-9. PubMed ID: 4024659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The induction of hepatic microsomal enzymes by safrole.
    Parke DV; Rahman H
    Biochem J; 1970 Oct; 119(5):53P-54P. PubMed ID: 5492830
    [No Abstract]   [Full Text] [Related]  

  • 9. Ligand-complex formation between cytochromes P-450 and P-448 and methylenedioxyphenyl compounds.
    Delaforge M; Ioannides C; Parke DV
    Xenobiotica; 1985 Apr; 15(4):333-42. PubMed ID: 4024668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of safrole and isosafrole pretreatment on N- and ring-hydroxylation of 2-acetamidofluorene by the rat and hamster.
    Lotlikar PD; Wasserman MB
    Biochem J; 1972 Oct; 129(4):937-43. PubMed ID: 4655827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structures of cysteine-containing peptides in isosafrole-inducible rat hepatic microsomal cytochrome P-450d: sequence homology with 3-methylcholanthrene-induced cytochrome P-450c.
    Haniu M; Ryan DE; Levin W; Shively JE
    Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4298-301. PubMed ID: 6589594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro formation of an inhibitory complex between an isosafrole metabolite and rat hepatic cytochrome P-450 PB-B.
    Murray M; Reidy GF
    Drug Metab Dispos; 1989; 17(4):449-54. PubMed ID: 2571488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic-intermediate complex formation reveals major changes in rat hepatic cytochrome P-450 subpopulations in addition to those forms previously purified after phenobarbital, beta-naphthoflavone, and isosafrole induction.
    Bornheim LM; Franklin MR
    Mol Pharmacol; 1982 Mar; 21(2):527-32. PubMed ID: 7099151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevention of CCl4-induced liver necrosis in mice by naturally occurring methylenedioxybenzenes.
    Zhao ZS; O'Brien PJ
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):411-21. PubMed ID: 8887459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further studies on the dissociation of the isosafrole metabolite-cytochrome P-450 complex.
    Dickins M; Elcombe CR; Moloney SJ; Netter KJ; Bridges JW
    Biochem Pharmacol; 1979; 28(2):231-8. PubMed ID: 426839
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: Properties of the safrole metabolite-cytochrome P-450 complex.
    Elcombe CR; Bridges JW; Netter KJ
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R72. PubMed ID: 1143487
    [No Abstract]   [Full Text] [Related]  

  • 17. Food restriction prevents the loss of isosafrole inducible cytochrome P-450 mRNA and enzyme levels in aging rats.
    Horbach GJ; Venkatraman JT; Fernandes G
    Biochem Int; 1990; 20(4):725-30. PubMed ID: 2353922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of piperonyl butoxide concentration on the formation of cytochrome P-450 difference spectra in hepatic microsomes from mice.
    Philpot RM; Hodgson E
    Mol Pharmacol; 1972 Mar; 8(2):204-14. PubMed ID: 4402004
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of cytochrome P-450c-mediated benzo[a]pyrene hydroxylase and ethoxyresorufin O-deethylase by dihydrosafrole.
    Kao LR; Wilkinson CF
    Xenobiotica; 1987 Jul; 17(7):793-805. PubMed ID: 3660849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of oxygenated cytochrome P-450 and of cytochrome b5 in hepatic microsomal drug oxidations.
    Baron J; Hildebrandt AG; Peterson JA; Estabrook RW
    Drug Metab Dispos; 1973; 1(1):129-38. PubMed ID: 4149374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.